According to Kella Kapnisi, the necessity for specially designed technologies is crucial because the cell and gene therapy sector is constantly changing. Real-time process ... 2.33 per basic ...

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Novartis is set to launch its one-off gene ... process (AMNOG) in Germany and this will be ongoing in the coming months, potentially making Germany one of the first countries to make gene ...

Dr Diego Correa is global head of the Cell and Gene Therapy Center of Excellence at IQVIA. Bringing more than two decades of basic and translational research experience in cell therapy ...

Your body remembers what your mind forgets. Discover how trauma lives in your cells and the breakthrough therapies that can ...

Reza Zafarqandi and his Indian and Uzbek counterparts have explored the potential for the expansion of health cooperation, ...

Hemophilia represents a rare, lifelong bleeding disorder characterized by the blood's inability to clot normally. While management strategies have advanced ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...